AGP Executive Report
Last update: 5 hours agoStroke Risk: A new population study finds first-ever stroke incidence among adults 20–54 nearly doubled in Greater Cincinnati/Northern Kentucky from the early 1990s to 2020, driven mainly by ischemic strokes even as 30-day fatality fell. FDA Approvals: The FDA cleared zilurgisertib (Atebrioz) for fibrodysplasia ossificans progressiva in patients 12+ and approved obinutuzumab (Gazyva) for idiopathic nephrotic syndrome; it also approved Welireg plus Lenvima for advanced clear cell renal cell carcinoma after PD-1/PD-L1 therapy. Diabetes Care: Once-weekly basal insulin options expanded again with FDA approval of insulin efsitora alfa-gobe (Onswik), with trial results showing noninferior A1C control and hypoglycemia differences in insulin-naive patients. Health IT & Access: Oracle Health is integrating ID.me digital identity to streamline patient portal check-in and record sharing; Ingenio Care launched a marketplace using CMS data to help patients compare cost and quality. Public Health & Safety: UNICEF warns acute malnutrition is rising sharply in Yemen amid conflict; Ohio indicted 18 Medicaid providers for fraud totaling $355,000+. Equity & Inclusion: The deaf community is calling for stronger recognition of sign language and equal access to services. Local Impact: Harnett County’s Board of Health received a top state award, and a Vasai-Virar initiative will provide free meals for patients under a health scheme.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.